MX9800133A - El uso de una leptina o mimetico de leptina para tratar la diabetes. - Google Patents

El uso de una leptina o mimetico de leptina para tratar la diabetes.

Info

Publication number
MX9800133A
MX9800133A MX9800133A MX9800133A MX9800133A MX 9800133 A MX9800133 A MX 9800133A MX 9800133 A MX9800133 A MX 9800133A MX 9800133 A MX9800133 A MX 9800133A MX 9800133 A MX9800133 A MX 9800133A
Authority
MX
Mexico
Prior art keywords
methods
treating diabetes
treating
obese type
diabetics
Prior art date
Application number
MX9800133A
Other languages
English (en)
Other versions
MXPA98000133A (es
Inventor
Thomas Wesley Stephens
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21692725&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX9800133(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MX9800133A publication Critical patent/MX9800133A/es
Publication of MXPA98000133A publication Critical patent/MXPA98000133A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2264—Obesity-gene products, e.g. leptin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat

Abstract

Esta invencion describe los métodos para el tratamiento de la diabetes en pacientes obesos diabéticos del tipo II. Específicamente, se reclaman los métodos para el tratamiento de los diabéticos obesos del tipo II, con niveles variantes de leptina endogena.
MXPA/A/1998/000133A 1995-06-30 1998-01-07 El uso de una leptina o mimetico de leptina paratratar la diabetes MXPA98000133A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US71895P 1995-06-30 1995-06-30
US000718 1995-06-30
PCT/US1996/010983 WO1997002004A2 (en) 1995-06-30 1996-06-26 Methods for treating diabetes

Publications (2)

Publication Number Publication Date
MX9800133A true MX9800133A (es) 1998-03-29
MXPA98000133A MXPA98000133A (es) 1998-10-15

Family

ID=

Also Published As

Publication number Publication date
NO976063L (no) 1998-02-16
KR19990028388A (ko) 1999-04-15
CN1195293A (zh) 1998-10-07
IL122718A0 (en) 1998-08-16
PL324284A1 (en) 1998-05-11
NO976063D0 (no) 1997-12-23
EA199800104A1 (ru) 1998-10-29
AU6479596A (en) 1997-02-05
HUP9802609A2 (hu) 1999-03-29
EP0836479A2 (en) 1998-04-22
CA2225454A1 (en) 1997-01-23
CZ416797A3 (cs) 1998-06-17
JPH11508895A (ja) 1999-08-03
WO1997002004A2 (en) 1997-01-23
US5756461A (en) 1998-05-26
AU695934B2 (en) 1998-08-27
WO1997002004A3 (en) 1997-05-22

Similar Documents

Publication Publication Date Title
WO1997002004A3 (en) Methods for treating diabetes
BG105079A (en) Glucagon-like peptide-1 improves beta-cell response to glucose in subjects with impaired glucose tolerance
CY1112034T1 (el) Μονοδιασπαρμενα μειγματα και μεθοδοι για την θεραπευτικη αγωγη του διαβητη
IL124109A0 (en) 2-alkylpyrrolidines
WO2004052284A3 (en) Treatment of diabetes
EP0908186A3 (en) Method for treating pain
WO2005107730A3 (en) Cysteamines for treating complications of hypercholesterolemia and diabetes
PT1051220E (pt) Conjunto de electrodo de electrotransporte com fraca resistencia inicial
HUP9700368A2 (hu) II-típusú diabetes mellitus kezelése amilin agonistákkal
EA200000747A1 (ru) СПОСОБ ВВЕДЕНИЯ AspB28-ИНСУЛИНА ЧЕЛОВЕКА
IL143569A0 (en) A combination of fbpase inhibitors and insulin sensitizers for the treatment of diabetes
DE69920885D1 (en) C-myc-bindendes protein "c-myc coding region determinant-binding protein (crd-bp)"
SE9201573D0 (sv) Use of igf-1
WO2000018954A3 (en) Use of pex in the treatment of metabolic bone diseases
GR3031250T3 (en) Methods of diagnosing and treating preeclampsia
AU2002353658A1 (en) Method of treating obesity, overweight, diabetes, or fluctuations in blood insuline or glucose levels
AU3308099A (en) Method for the treatment of pain, including chronic and female specific pain
PT869785E (pt) 4-hidroxicumarina-3-carboxamidas para o tratamento de diabetes mellitus nao insulinodependente
GB9818650D0 (en) Therapeutic compounds and methods of making and using the same
WO2003047421A3 (en) Methods and reagents for diagnosis and treatment of diabetes
UA32295A (uk) Спосіб лікування порушень фертильності у хворих на цукровий діабет
UA20075A (uk) Спосіб діагhостуваhhя та лікуваhhя стійких фуhкціоhальhих зміщеhь hижhьої щелепи
UA33330A (uk) Спосіб діагностики ендогенної інтоксикації
UA33061A (uk) Спосіб лікування глибоких опіків
UA19649A (uk) Метод діагhостики еhдогеhhої іhтоксикації